About Tigermed
Welcome to Tigermed
Tigermed (Stock code: 300347.SZ/3347.HK) is a leading provider of innovative clinical research solutions across full lifecycle of biopharmaceutical and medical device products globally. With a broad portfolio of services and a promise of quality, from clinical development to commercialization, we are committed to moving our customers and patients through their development journey efficiently and cost-effectively, embracing challenges to fulfill our commitment to serve unmet patients’ needs, and eventually saving lives.
Mission
Serve healthcare partners through innovation, advance human health through excellence.
We are committed to improving health by accelerating the development of innovative and effective treatments for patients everywhere. We aim to excel in clinical trials for the benefit of our clients and patients worldwide by providing our services with fundamental principles like quality, innovation, integrity, and ethical conduct at the core of everything we do.
Vision
To be recognized as the leading CRO.
We constantly support our clients in advancing human health by delivering science-based value and real outcomes. Our aim is to solidify our market leadership and foster a flourishing ecosystem that contributes to the sustainable and long-term growth of the healthcare industry.
A Company Built on Values
Honest &
Reliable
Open &
Inclusive
Professional &
Innovative
Collaborative &
Accountable
To be consistent and uncompromising in our moral and ethical principles in clinical development.
To promote collaboration among cultures and sharing our knowledge and values with others unconditionally.
To respect authorities, clients, colleagues, and all those we collaborate with to deliver high-quality results that matter.
To provide our clients with any information required science-based decision making, honor our commitments, and take ownership of our work.
Learn More about Our History
Since our inception in 2004, Tigermed has been developing and expanding steadily. We have been adding expertise to our portfolio, experienced colleagues to our teams and subsidiaries to the Tigermed group ever since.
A Trusted Partner with Proven Expertise
We are committed to providing our clients with integrated R&D services and solutions in their clinical development in the best possible way.
Every project we conduct and every customer we serve, we do it with excellence. And we are devoted to be excellent in every trial, for every patient.
Since our founding in 2004, we have established a comprehensive suite of biopharmaceutical R&D service offerings, ranging from pre-clinical to commercialization, and primarily focus on clinical stage, including regulatory affairs and submission, clinical operations, data management and statistical analysis, technology platform, medical device, post-marketing and real-world study.
Global Footprint
As of Q2 2021, Tigermed is representing a global network of more than 60 subsidiaries and 160 offices and service locations, with over 7,500 employees across 39 countries in Asia Pacific, Europe, North America, South America and Africa.
This set-up enables Tigermed to provide our clients with support in both local expertise in China and global clinical development programs.
Corporate Leadership
A Team with Professional Expertise and Innovative Ideas.
Corporate Awards
Customer Recognition is Our Driving Force.
